Plasma Tau Corresponds to Preclinical Alzheimer's Disease and is a Strong Predictor of Future Dementia

被引：0
|
作者：
Pase, Matthew [1 ]
Beiser, Alexa [3 ]
Himali, Jayandra [2 ]
Satizabal, Claudia [4 ]
Aparicio, Hugo Javier [5 ]
DeCarli, Charles [6 ]
Seshadri, Sudha [2 ]
机构：
[1] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA
[4] Boston Univ, Framingham Study, Boston, MA USA
[5] Boston Univ, Boston, MA 02215 USA
[6] Dept Neurol, Sacramento, CA USA
来源：
NEUROLOGY | 2018年 / 90卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S48.001
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Plasma phosphorylated tau 217 in preclinical Alzheimer's disease
    Jonaitis, Erin M.
    Janelidze, Shorena
    Cody, Karly A.
    Langhough, Rebecca
    Du, Lianlian
    Chin, Nathaniel A.
    Mattsson-Carlgren, Niklas
    Hogan, Kirk J.
    Christian, Bradley T.
    Betthauser, Tobey J.
    Hansson, Oskar
    Johnson, Sterling C.
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [2] Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease
    Yang, Hyun-Sik
    Yau, Wai-Ying Wendy
    Carlyle, Becky C.
    Trombetta, Bianca A.
    Zhang, Can
    Shirzadi, Zahra
    Schultz, Aaron P.
    Pruzin, Jeremy J.
    Fitzpatrick, Colleen D.
    Kirn, Dylan R.
    Rabin, Jennifer S.
    Buckley, Rachel F.
    Hohman, Timothy J.
    Rentz, Dorene M.
    Tanzi, Rudolph E.
    Johnson, Keith A.
    Sperling, Reisa A.
    Arnold, Steven E.
    Chhatwal, Jasmeer P.
    BRAIN, 2024, 147 (06) : 2158 - 2168
  • [3] Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
    Sebastian Palmqvist
    Pontus Tideman
    Nicholas Cullen
    Henrik Zetterberg
    Kaj Blennow
    Jeffery L. Dage
    Erik Stomrud
    Shorena Janelidze
    Niklas Mattsson-Carlgren
    Oskar Hansson
    Nature Medicine, 2021, 27 : 1034 - 1042
  • [4] Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures
    Palmqvist, Sebastian
    Tideman, Pontus
    Cullen, Nicholas
    Zetterberg, Henrik
    Blennow, Kaj
    Dage, Jeffery L.
    Stomrud, Erik
    Janelidze, Shorena
    Mattsson-Carlgren, Niklas
    Hansson, Oskar
    NATURE MEDICINE, 2021, 27 (06) : 1034 - +
  • [5] Plasma tau levels in Alzheimer's disease
    Zetterberg, Henrik
    Wilson, David
    Andreasson, Ulf
    Minthon, Lennart
    Blennow, Kaj
    Randall, Jeffrey
    Hansson, Oskar
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (02):
  • [6] Plasma tau levels in Alzheimer's disease
    Henrik Zetterberg
    David Wilson
    Ulf Andreasson
    Lennart Minthon
    Kaj Blennow
    Jeffrey Randall
    Oskar Hansson
    Alzheimer's Research & Therapy, 5
  • [7] APOE effects on regional tau in preclinical Alzheimer's disease
    Young, Christina B.
    Johns, Emily
    Kennedy, Gabriel
    Belloy, Michael E.
    Insel, Philip S.
    Greicius, Michael D.
    Sperling, Reisa A.
    Johnson, Keith A.
    Poston, Kathleen L.
    Mormino, Elizabeth C.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [8] Tau positron emission tomography in preclinical Alzheimer's disease
    Insel, Philip S.
    Young, Christina B.
    Aisen, Paul S.
    Johnson, Keith A.
    Sperling, Reisa A.
    Mormino, Elizabeth C.
    Donohue, Michael C.
    BRAIN, 2023, 146 (02) : 700 - 711
  • [9] Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Gordon, Brian A.
    Goyal, Manu S.
    Su, Yi
    Blazey, Tyler M.
    Durbin, Tony J.
    Couture, Lars E.
    Christensen, Jon J.
    Jafri, Hussain
    Morris, John C.
    Raichle, Marcus E.
    Benzinger, Tammie L. -S.
    NEUROBIOLOGY OF AGING, 2018, 67 : 95 - 98
  • [10] APOE effects on regional tau in preclinical Alzheimer’s disease
    Christina B. Young
    Emily Johns
    Gabriel Kennedy
    Michael E. Belloy
    Philip S. Insel
    Michael D. Greicius
    Reisa A. Sperling
    Keith A. Johnson
    Kathleen L. Poston
    Elizabeth C. Mormino
    Molecular Neurodegeneration, 18
12345